Molecular and genetic testing has become a game-changer in brain tumor care - shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these ...
A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with ...
(a) Peripheral blood smear in a patient with the chronic phase of chronic myeloid leukemia (CML) before treatment; (b) Detection of BCR::ABL1 fusion gene, p210 by RNA sequencing; (c) Peripheral blood ...
Current Practices, Perceived Barriers, and Promising Implementation Strategies for Improving Quality of Smoking Cessation Support in Accredited Cancer Programs of the American College of Surgeons This ...
In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...
A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return within 18 months of treatment, a study has found. This method picks up ...
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results